GeneDx Holdings Corp. (WGS)
89.52
+2.12
(+2.42%)
USD |
NASDAQ |
Aug 26, 13:42
GeneDx Holdings Enterprise Value : 2.640B for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 2.640B |
| August 24, 2026 | 2.574B |
| August 21, 2026 | 2.630B |
| August 20, 2026 | 2.495B |
| August 19, 2026 | 2.409B |
| August 18, 2026 | 2.310B |
| August 17, 2026 | 2.341B |
| August 14, 2026 | 2.362B |
| August 13, 2026 | 2.394B |
| August 12, 2026 | 2.490B |
| August 11, 2026 | 2.471B |
| August 10, 2026 | 2.356B |
| August 07, 2026 | 2.332B |
| August 06, 2026 | 2.109B |
| August 05, 2026 | 2.118B |
| August 04, 2026 | 2.148B |
| August 03, 2026 | 2.057B |
| July 31, 2026 | 1.975B |
| July 30, 2026 | 2.090B |
| July 29, 2026 | 1.933B |
| July 28, 2026 | 1.879B |
| July 27, 2026 | 1.839B |
| July 24, 2026 | 1.796B |
| July 23, 2026 | 1.924B |
| July 22, 2026 | 1.901B |
| Date | Value |
|---|---|
| July 21, 2026 | 1.872B |
| July 20, 2026 | 1.842B |
| July 17, 2026 | 1.927B |
| July 16, 2026 | 1.873B |
| July 15, 2026 | 2.006B |
| July 14, 2026 | 1.895B |
| July 13, 2026 | 1.938B |
| July 10, 2026 | 1.991B |
| July 09, 2026 | 2.103B |
| July 08, 2026 | 1.991B |
| July 07, 2026 | 1.985B |
| July 06, 2026 | 2.088B |
| July 02, 2026 | 2.047B |
| July 01, 2026 | 2.172B |
| June 30, 2026 | 2.081B |
| June 29, 2026 | 2.048B |
| June 26, 2026 | 2.069B |
| June 25, 2026 | 2.035B |
| June 24, 2026 | 1.883B |
| June 23, 2026 | 1.721B |
| June 22, 2026 | 1.642B |
| June 18, 2026 | 1.748B |
| June 17, 2026 | 1.671B |
| June 16, 2026 | 1.795B |
| June 15, 2026 | 1.817B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CS Diagnostics Corp. | 2.620M |
| Aibotics, Inc. | 1.418M |
| GRAIL, Inc. | 2.916B |
| Ayujoy Herbals Ltd. | -- |
| Twist Bioscience Corp. | 9.417B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.74M |
| Revenue (Quarterly) | 114.44M |
| Total Expenses (Quarterly) | 132.18M |
| EPS Diluted (Quarterly) | -0.5971 |
| Gross Profit Margin (Quarterly) | 64.05% |
| Profit Margin (Quarterly) | -15.50% |
| Earnings Yield | -4.05% |
| Normalized Earnings Yield | -2.910 |